dual glp 1 and gip receptor agonist Main physiological actions of the GLP-1 Major physiological roles of GLP-1

CBS News medical correspondent Dr

Limited evidence suggests that combined SGLT2is/GLP1-RAs therapy can potentially improve most but not all outcomes

#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn

For example, merely switching from one dose per week (q1wk) to one dose every two weeks (q2wk) maintains roughly 75% of the weight loss

Overall, the study supports current guideline flexibility, indicating that both GLP-1RAs and SGLT2 inhibitors provide broadly similar cardiovascular protection

Conclusion GLP-1 RA therapy has a respiratory safety profile that is neither uniformly benign nor hazardous, stratified by mechanism, agent subclass, and clinical context